Profile
Walter O.
Fredericks has been a Director of Matritech, Inc. since July 2003.
From 2002 to 2006, Mr. Fredericks was a Member of Financial Affairs for Adirondack Boat LLC.
From 1991 to 2001, he was President, Chief Executive Officer and a Director of Lifecodes Corp.
Mr. Fredericks was Founder of Electronic Instruments International and Chief Executive Officer and a Director from 1993 to 2001.
From 1989 to 1997, he was a Director of DIANON Systems, Inc.
Former positions of Walter O. Fredericks
| Companies | Position | End |
|---|---|---|
MZT Holdings, Inc.
 MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | Director/Board Member | 2008-01-21 |
Matritech, Inc.
 Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Director/Board Member | 2007-12-12 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Matritech, Inc.
Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Health Technology |
MZT Holdings, Inc.
MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | Health Technology |
- Stock Market
- Insiders
- Walter O. Fredericks
